| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 85.4501 | 73 |
| GSM780708 | Untreated after 4 days (C2_1) | 80.5395 | 72 |
| GSM780709 | Untreated after 4 days (C3_1) | 95.0362 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 78.8245 | 71 |
| GSM780720 | Untreated after 4 days (C2_2) | 86.2194 | 73 |
| GSM780721 | Untreated after 4 days (C3_2) | 92.2768 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 86.2996 | 73 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 90.8979 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 104.852 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 96.1601 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 101.204 | 75 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 83.4202 | 72 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 136.327 | 79 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 86.7446 | 73 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 123.9 | 78 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 136.207 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 86.4691 | 73 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 113.05 | 77 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 77.572 | 71 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 86.6301 | 73 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 72.6047 | 70 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 77.0333 | 71 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 96.5303 | 75 |